Stay updated with breaking news from Erick Rowinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twenty-seven analysts that are covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12-month price objective […]
Camelot Portfolios LLC raised its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 81.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the biotechnology company’s stock after acquiring an additional 900 shares during […]
Altfest L J & Co. Inc. raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 13.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,433 shares of the biotechnology company’s stock after buying an additional 174 shares during the period. Altfest L […]
Wellington Management Group LLP increased its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.5% in the third quarter, Holdings Channel reports. The institutional investor owned 5,374,310 shares of the biotechnology company’s stock after acquiring an additional 27,951 shares during the period. Wellington Management Group LLP’s holdings in Biogen were worth $1,381,251,000 at the […]
Carmignac Gestion cut its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 309,100 shares of the biotechnology company’s stock after selling 1,000 shares during the quarter. Biogen accounts for approximately 1.5% of […]